CCHE White Paper Launch

Changing the Way We Think About Drug Prices:
Insights From Economics

Institute of Health Policy Management & Evaluation and

Canadian Centre for Health Economics, University of Toronto

October 28, 2015
MaRS Centre, (West Tower, Multi-Purpose Room (MPR)),
101 College Street, Toronto, ON

Host & White Paper Sponsor: Novartis Oncology
Moderator: Dr. Zayna Khayat (MaRS)
Dr. Audrey Laporte (IHPME and CCHE)
Dr. Brian Ferguson (University of Guelph and CCHE)
Ms. Finn Doyle (GM, Novartis Oncology)

Dr. Adalsteinn Brown (IHPME)
Louise Binder (Canadian Cancer Survivor Network)
Saad Rafi (former Deputy Minister of Health & Long Term Care)

Dr. Zayna Khayat

Zayna Khayat

Dr. Zayna Khayat is a senior advisor in health system innovation at MaRS Discovery District, an innovation hub in Toronto with a major focus on the health sector. She is also Director of the MaRS EXCITE health technology evaluation program. Zayna’s mission is to help healthcare systems in Ontario, Canada and around the world adopt health technology that improves public health while driving the Canadian knowledge economy. Dr. Khayat is also adjunct professor in health sector strategy at the Rotman School of Management at University of Toronto. Zayna was previously director of development at the Ivey International Centre for Health Innovation at Western University.

Prior to this, she had an 11-year career in strategy consulting in the global health and life sciences sector, first with the Boston Consulting Group’s Toronto office from 2001 to 2010, and then as an associate principal with SECOR/KPMG. She holds a PhD in biochemistry from the University of Toronto and the Hospital for Sick Children, with a focus on insulin action and diabetes. She lives in Toronto with her husband and three children. LinkedIn: | Twitter: @ZaynaKhayat | E-mail:

Dr. Audrey Laporte

Audrey Laporte

Prof. Audrey Laporte is an Associate Professor with the Institute of Health Policy, Management and Evaluation (IHPME) at the University of Toronto. She has expertise in advancing econometric modelling of efficiency in health care including quantile regression and dynamic econometric modelling and also theoretical dynamic modelling of the demand for health.

She has published in leading health economics and health services research journals and supervised numerous doctoral students in policy related areas of health economics. Prof. Laporte is the Director of the Canadian Centre for Health Economics.

Dr. Brian Ferguson

Brian Ferguson

Brian Ferguson, is Professor, Department of Economics, University of Guelph and Faculty Associate, Canadian Centre for Health Economics.

He brings expertise in mathematical economics and microeconomic theory as applied to health and health care. He has written several policy papers on various issues in health policy and is one of the leading senior health economists in Canada.

Finn Doyle

Finn Doyle
As Oncology General Manager of Novartis Pharmaceuticals Canada Inc. Finn Doyle manages a team of more than 150 associates who are all united in their purpose to ensure that all patients who could benefit from the Novartis Oncology portfolio of products and solutions are able to do so.

As Oncology General Manager of Poland from 2010 to 2013, Finn and Team Poland delivered sustained success by focusing on their purpose of “fighting FOR patients”. In a complex reimbursement market the team introduced new ways to gain access to innovative medicines.

Finn began her career with Novartis in 2003 as the Business Unit Head of the CNS Franchise in Ireland where she created an award winning patient documentary on the impact of schizophrenia on their lives and the hope provided by succesful medication. In 2006, Finn made her transition into the Oncology space as the Business Unit Head for Ireland & UK where she built new capabilities in the Medical and Market Access functions.

Prior to Novartis Finn held various roles in marketing and sales at Abbott Laboratories and Rowa Pharmaceuticals. Early in her career she spent time in academic research.

Finn has a Bachelor of Science (Honours) degree in biochemistry and clinical nutrition from the University of Dublin, Trinity College as well as a Graduate Membership, MMII (Grad) from the Marketing Institute of Ireland. She is bilingual and has a basic knowledge of Italian and Spanish. She has a passion for travel and an intense curiousity for people and cultures.


Dr. Adalsteinn Brown,
Chair, Public Health Policy, Dalla Lana School of Public Health, University of Toronto, Canada & Member, Cancer Quality Council of Ontario, Canada

Adalsteinn Brown
Dr. Steini Brown became the Dalla Lana Chair of Public Health Policy at the University of Toronto and a Scientist in the Keenan Research Centre of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital on the first of January, 2011.

Past roles span the public, private, and government sectors and include Assistant Deputy Minister for strategy at the Ontario Ministry of Health and Long-term Care and for science and research at the Ontario Ministry of Research and Innovation, Principal Investigator for the Ontario Hospital Repot Card project, and a founding role in consulting, software, and internet companies.

Dr. Brown received his bachelor’s degree in government from Harvard University and his doctorate from the University of Oxford, where he was a Rhodes Scholar. In 2003, he was named one of Canada’s Top 40 under 40 in recognition for his work on performance measurement in health care.

Louise Binder


Louise Binder

Louise Binder is a lawyer who has been involved in informing the development of health policy and systemic treatment access practices from a patient perspective for more than 20 years. She started her work in this area in the HIV community in the early 1990s after her own diagnosis and before effective treatments were available for HIV. She cofounded the Canadian Treatment Action Council (CTAC) in 1996 that successfully ensured access to treatments and quality care for people living with HIV by working with the federal and provincial governments and other relevant stakeholders to enhance drug review and approval systems, pricing policies and access to liver transplants for this community. She wrote a paper on Universal Drug Coverage a decade ago while Chair of CTAC.

She had a special interest in women’s issues, chairing the Ontario women’s organization Voice of Positive Women for over a decade. She has been involved in these issues internationally as well. Two years ago Louise began similar work in the cancer area and is presently Health Policy Consultant for the Canadian Cancer Survivor Network years ago.

She has been recognized by many organizations for her work including receiving an Honorary Doctorate of Laws from her alma mater Queen’s Law School, the Order of Ontario from the province of Ontario and two Queen Elizabeth II medals.

Saäd Rafi

Saad Rafi
In January 2014, Saäd Rafi joined the TORONTO 2015 Pan Am/Parapan Am Games Organizing Committee (TO2015) as Chief Executive Officer. He brings a wealth of experience in delivering largescale transformation, change management and project management to Ontario’s public and private sectors.

Rafi served most recently as deputy minister of the Ministry of Health and Long-Term Care. Between 2010 and 2014, he administered an annual budget of $49 billion — the largest health budget in Canada — and oversaw one of the most significant system transformations in Ontario’s health-care sector.

During his 25-year career, he served in three other different Deputy Minister roles and he also built a successful advisory practice in infrastructure and project finance while as a partner with Deloitte and Touche, LLP.